Home › Chronic Kidney Disease › NCT06978127

Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients

Technology Assisted Collaborative Care Intervention (TĀCcare) 2.0 Implementation Trial to Improve Patient-centered Outcomes in Patients on Hemodialysis

Who can join

Ages 18 and older · All sexes

Eligibility Criteria:

1. age 18 years or older;
2. undergoing thrice-weekly maintenance hemodialysis (HD) for \> 3 months;
3. English or Spanish speaking;
4. able to provide informed consent

Ineligibility Criteria:

1. active thought disorder, delusions or active suicidal ideation
2. active substance abuse
3. enrolled in hospice or life expectancy \< 6 months (based on clinician's judgement)
4. too ill or cognitively impaired to participate based on renal provider's judgement
5. living kidney transplant scheduled in \<3 months
6. undergoing active cancer treatment.
7. enrolled in another research study
8. plan to transition to home dialysis within 3 months
9. plan to move to another dialysis facility within 3 months

About the study

The goal of this study is to learn if a collaborative care intervention of pharmaco-therapy and/or cognitive behavioral therapy (CBT), delivered in a real-world setting, improves symptoms of pain, fatigue and/or depression.

What is being tested

• Technology Assisted Stepped Collaborative Care (behavioral)
• Usual Care Arm (other)

Sponsor: University of Pittsburgh · Participants: 424 · Started: Aug 28, 2025

Contact the study team

• Manisha Jhamb, MD, MPH · Phone: 412-647-7062
• Mark Unruh, MD, MS · Phone: (505) 272-0407

Official record on ClinicalTrials.gov — NCT06978127

Locations in the U.S.

Conditions

• Chronic Kidney Disease
• Pain
• Depression
• Fatigue

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.